PIK3CA and cholangiocarcinoma: The frequent co-occurrence of ARID1A loss with PIK3CA mutations in various cancers, including TNBC, ovarian clear cell carcinoma, and cholangiocarcinoma, highlights the vital role of ARID1A and PI3K/AKT in tumorigenesis.